Information about thoracic aortic aneurysms (TAAs) and their minimally invasive treatment with the Valiant Captivia Thoracic Stent Graft System.
The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.
“The expanded offering of the Valiant Captivia Stent Graft in these major global markets epitomizes our commitment to globalization,” said
The international market leader in its product category, the Valiant Captivia Stent Graft is approved by the
A thoracic aortic aneurysm (TAA) is a dangerous bulge in the body’s main artery near where it branches off the heart. The eventual outcome of an untreated thoracic aortic aneurysm is rupture, an emergency situation in which the artery bursts, causing extensive internal bleeding that usually leads to death.
Thoracic stent grafts are tubular medical devices that physicians deliver through a pre-loaded catheter that is inserted in the patients’ femoral arteries. Once deployed, the stent graft conforms to the wall of the aorta, the body’s main artery, creating a new path for blood flow.
The Valiant Captivia Stent Graft System updates earlier generation devices by featuring an eight-peak crown that effectively secures the deployed device inside the aorta. It is also more flexible and conformable through the elimination of the longitudinal connecting bar found in other stent grafts.
A blunt thoracic aortic injury is an emergency medical condition in which the aorta is damaged due to traumatic force to the chest, usually the result of motor accidents, elevated falls or other high-impact injuries. It is the second leading cause of traumatic death after head injuries.
Fifty patients at 20 U.S. sites were enrolled in RESCUE to investigate the safety and effectiveness of stent grafts for the treatment of BTAI. Early results on the first 33 patients enrolled in the study were presented in late March at the 2012 Annual Scientific Meeting of the
“Traditionally, the mortality rates associated with surgical repair of blunt thoracic aortic injuries range from 15 to 20 percent,” said Dr.
RESCUE is one of several clinical studies of the Valiant Thoracic Stent Graft. Other
In collaboration with leading clinicians, researchers and scientists worldwide,
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the
Joe McGrath, 707-591-7367
Jeff Warren, 763-505-2696